NCT05126628View on ClinicalTrials.gov

The South Proxa-Rescue AndroCoV Trial Against COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

March 6, 2021

Primary Completion Date

March 16, 2021

Study Completion Date

April 15, 2021

Conditions
COVID-19
Interventions
DRUG

Proxalutamide

Proxalutamide 300mg q.d.(3 tablets of 100mg each) for 14 days.

DRUG

Placebo

Placebo 3 tablets q.d. for 14 days

Trial Locations (1)

70390-150

Corpometria Institute, Brasília

All Listed Sponsors
collaborator

Hospital da Brigada Militar de Porto Alegre, Porto Alegre, Brazil

UNKNOWN

collaborator

Hospital Arcanjo Sao Miguel, Gramado, Brazil

UNKNOWN

collaborator

Hospital Unimed Chapeco, Chapeco, Brazil

UNKNOWN

lead

Corpometria Institute

OTHER

NCT05126628 - The South Proxa-Rescue AndroCoV Trial Against COVID-19 | Biotech Hunter | Biotech Hunter